Marblegate Capital MGTE
OTC MGTE
$1.34 -0.02 (-1.47%)
As of: Aug 19, 2026 · 9:59 AM EDT

Marblegate Capital (MGTE) Return on Sales (2024 - 2026)

Marblegate Capital's (MGTE) quarterly Return on Sales came in at 0.04% in Q4 2025, up 5.0% YoY from 0.04% in Q4 2024, and up 4162.21% on a QoQ basis from 0.0% in Q3 2025.

Marblegate Capital (MGTE) Return on Sales (2024 - 2026) Analysis & Trends

Marblegate Capital (MGTE) has 2 years of Return on Sales data on file, last reported at 0.04% in Q4 2025.

  • Quarterly Return on Sales rose 5.0% year-over-year to 0.04% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
  • Return on Sales grew to 0.04% in Q4 2025, from 0.0% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.04% in Q4 2025 to a low of 0.47% in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - -
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - -
3 Drugs Made In America Acquisition 506.00 Mn 506.00 Mn - -
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn - -
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn - -
6 Aldel Financial 397.49 Mn 397.49 Mn - -
7 Republic Digital Acquisition 389.25 Mn 388.51 Mn - -
8 Gores Holdings X 385.06 Mn 384.87 Mn - -
9 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - 0.00%
10 Marblegate Capital 87.22 Mn 180.32 Mn - 0.00%

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00%
Dec 31, 2025 0.04%
Sep 30, 2025 0.00%
Jun 30, 2025 -0.03%
Mar 31, 2025 0.00%
Dec 31, 2024 -0.01%
Sep 30, 2024 0.02%
Jun 30, 2024 0.00%
Mar 31, 2024 -0.47%